Nykode Therapeutics AS (VACBF) Stock Price, News & Analysis

Company Overview

Nykode Therapeutics AS is a Norwegian biotechnology company focused on developing targeted immunotherapies for cancer and autoimmune diseases. The company’s approach is designed to direct therapeutic payloads to specific immune cells, with the goal of generating targeted and durable immune responses.

Nykode’s technology platform, originally developed under the Vaccibody name, uses modular molecules that can target antigens to antigen-presenting cells and stimulate both cellular and antibody-based immunity. Its development programs have included personalized cancer vaccines and therapeutic vaccines aimed at cancers associated with human papillomavirus, including programs known as VB10.NEO and VB10.16.

Founded in Norway and formerly known as Vaccibody, the company changed its name to Nykode Therapeutics in 2021. It conducts research and development activities in Europe and has pursued collaborations and clinical development programs intended to support the advancement of its immunotherapy pipeline internationally.

Key Stats

• Today's Range: $0.45 to $0.45
• 50-Day Range: $0.32 to $0.45
• 52-Week Range: $0.32 to $0.45
• Volume: N/A
• Average Volume: 1,000 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Current Symbol: OTCMKTS:VACBF
• CIK: N/A
• Web: nykode.com
• Phone: 47-22-95-81-93
• Fax: N/A
• Employees: 171
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A